Breaking News Instant updates and real-time market news.

TEVA

Teva

$45.19

-0.07 (-0.15%)

08:01
10/06/16
10/06
08:01
10/06/16
08:01

Teva, Celltrion announce exclusive biosimilar commercial relationship

Teva Pharmaceutical, Celltrion, Inc. and Celltrion Healthcare announce that the companies have entered into an exclusive partnership to commercialize two of Celltrion's mAb biosimilar candidates in the U.S. and Canada. CT-P10 is a proposed mAb biosimilar to Rituxan, which is used to treat patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Wegener's Granulomatosis and Microscopic Polyangiitis. CT-P6 is a proposed mAb biosimilar to Herceptin, which is used for the treatment of HER2-overexpressing breast cancer and for the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Combined annual net sales for Rituxan and Herceptin are approximately $6.5B in the U.S. and Canada. Both CT-P10 and CT-P6 are currently in late-stage Phase III development and their primary endpoints have been successfully achieved. CT-P10 was submitted by Celltrion to the European Medicines Agency for review in October 2015. In the meantime, Celltrion is preparing CT-P6 for submission in Europe seeking approval from the EMA this quarter. As part of the agreement, Teva will be responsible for all commercial activities in the U.S. and Canada, pending regulatory approvals for both products. Celltrion has responsibility for completing all clinical development and regulatory activities. Under the terms of the agreement, Teva will pay Celltrion Healthcare $160M upfront of which up to $60M is refundable or creditable under certain circumstances. Teva and Celltrion Healthcare will share profit from the commercialization of the mAb biosimilars.

  • 06

    Nov

  • 15

    Nov

TEVA Teva
$45.19

-0.07 (-0.15%)

09/23/16
LEER
09/23/16
NO CHANGE
LEER
Outperform
Positive data paves way for Teva SD-809 indication, says Leerink
Leerink analyst Jason Gerberry says the AIM-TD study readout clinically de-risks Teva's (TEVA) SD-809 opportunity for tardive dyskinesia, with the investor focus shifting to market size and competitive differentiation versus Neurocrine's (NBIX) valbenazine. The analyst believes Teva's SD-809 is well positioned to compete against valbenazine with an equally efficacious and well tolerated drug. Further, he expects Teva to exit 2017 with a broader label. Gerberry reiterates an Outperform rating on Teva's shares.
09/29/16
OTRG
09/29/16
INITIATION
OTRG
Positive
Teva initiated with a Positive at OTR Global
10/03/16
WELS
10/03/16
NO CHANGE
WELS
Outperform
Teva shares suffering from lack of catalysts, says Wells Fargo
Wells Fargo analyst David Maris attributes the continued slide in Teva (TEVA) shares largely to negative sector news such as the drug pricing debate, fears on generic pricing, and Mylan's (MYL) EpiPen issue, but also thinks the slide has been made worse by Teva's lack of near-term catalysts. Additionally, the ongoing Copaxone generic trial and Teva's recently filed suit against Rimsa's founders over allegedly being misled by the Mexican pharmaceutical company have added to the pressure, Maris noted. Maris acknowledges there may be "no notable catalysts" for the rest of the year for Teva, but he thinks it should be a "robust 2017" for the company and keeps an Outperform rating on the shares.
10/05/16
WELS
10/05/16
NO CHANGE
WELS
Outperform
Teva estimates lowered on generic trends at Wells Fargo
Wells Fargo analyst David Maris lowered his estimates for Teva (TEVA) for this year and next, citing expectations for lower generic sales this year and lower margins in the generic business. Maris lowered his price target range for Teva shares to $60-$61 from $70-73 based on his lower estimates as well as the uncertainty of the environment, but keeps an Outperform rating on shares citing valuation and his belief 2017 should be a better year with several pipeline events for Teva.

TODAY'S FREE FLY STORIES

NKE

Nike

$53.24

0.01 (0.02%)

, AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

10:45
09/26/17
09/26
10:45
09/26/17
10:45
Earnings
On The Fly: What to watch in Nike's earnings report »

Nike (NKE) is scheduled…

NKE

Nike

$53.24

0.01 (0.02%)

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

UA

Under Armour

$15.43

0.04 (0.26%)

UAA

Under Armour

$16.68

-0.06 (-0.36%)

ADDYY

adidas

$113.80

-1.22 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 03

    Oct

  • 04

    Oct

  • 22

    Oct

ADDYY

adidas

$113.80

-1.22 (-1.06%)

10:45
09/26/17
09/26
10:45
09/26/17
10:45
Hot Stocks
Adidas says will 'fully cooperate with authorities' after arrest of employee »

Adidas issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
09/26/17
09/26
10:45
09/26/17
10:45
General news
FX Action: The dollar »

FX Action: The dollar…

GOOG

Alphabet

$920.97

-7.56 (-0.81%)

, GOOGL

Alphabet Class A

$934.28

-8.98 (-0.95%)

10:43
09/26/17
09/26
10:43
09/26/17
10:43
Periodicals
Google to split off shopping service to comply with EU demands, Bloomberg says »

Google is planning to…

GOOG

Alphabet

$920.97

-7.56 (-0.81%)

GOOGL

Alphabet Class A

$934.28

-8.98 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

JPM

JPMorgan

$93.78

-0.34 (-0.36%)

, PNC

PNC Financial

$132.92

-0.6 (-0.45%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Hot Stocks
Deutsche moves to the sidelines on JPMorgan, PNC »

Shares of JPMorgan (JPM)…

JPM

JPMorgan

$93.78

-0.34 (-0.36%)

PNC

PNC Financial

$132.92

-0.6 (-0.45%)

GS

Goldman Sachs

$230.47

0.21 (0.09%)

WFC

Wells Fargo

$54.07

0.04 (0.07%)

MS

Morgan Stanley

$47.55

-0.19 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 12

    Oct

  • 13

    Oct

  • 13

    Oct

  • 17

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

RGEN

Repligen

$43.22

-0.54 (-1.23%)

, GE

General Electric

$25.12

0.01 (0.04%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Recommendations
Repligen, General Electric analyst commentary  »

Stephens sees GE resin as…

RGEN

Repligen

$43.22

-0.54 (-1.23%)

GE

General Electric

$25.12

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 02

    Oct

  • 30

    Nov

WEN

Wendy's

$14.91

-0.13 (-0.86%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Options
Bullish flow in Wendy's as call buyers gobble up new positions »

Bullish flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 22

    Oct

10:40
09/26/17
09/26
10:40
09/26/17
10:40
General news
Fed governor Brainard steered clear of policy »

Fed governor Brainard…

10:35
09/26/17
09/26
10:35
09/26/17
10:35
General news
U.S. consumer confidence slipped to 119.8 »

U.S. consumer confidence…

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

10:34
09/26/17
09/26
10:34
09/26/17
10:34
Downgrade
Cardtronics rating change  »

Cardtronics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$35.48

-0.03 (-0.08%)

10:30
09/26/17
09/26
10:30
09/26/17
10:30
Options
Bullish option flow in Pfizer »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 18

    Oct

  • 31

    Oct

  • 08

    Nov

10:30
09/26/17
09/26
10:30
09/26/17
10:30
General news
U.S. Richmond Fed's manufacturing index rose to 19 in September »

U.S. Richmond Fed's…

NSRGY

Nestle

$83.75

0.88 (1.06%)

, VZ

Verizon

$49.83

-0.075 (-0.15%)

10:29
09/26/17
09/26
10:29
09/26/17
10:29
Hot Stocks
Nestle sets new profit targets, though stance on L'Oreal stake unchanged »

Shares of Nestle (NSRGY)…

NSRGY

Nestle

$83.75

0.88 (1.06%)

VZ

Verizon

$49.83

-0.075 (-0.15%)

LRLCY

L'Oreal

$43.13

-0.19 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 19

    Oct

RGEN

Repligen

$43.22

-0.54 (-1.23%)

, GE

General Electric

$25.09

-0.025 (-0.10%)

10:28
09/26/17
09/26
10:28
09/26/17
10:28
Recommendations
Repligen, General Electric analyst commentary  »

GE launch to weight on…

RGEN

Repligen

$43.22

-0.54 (-1.23%)

GE

General Electric

$25.09

-0.025 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 02

    Oct

  • 30

    Nov

ADDYY

adidas

$113.80

-1.22 (-1.06%)

, NKE

Nike

$53.21

-0.025 (-0.05%)

10:28
09/26/17
09/26
10:28
09/26/17
10:28
Periodicals
Adidas, Nike employees reportedly named in FBI corruption probe »

The head of sports…

ADDYY

adidas

$113.80

-1.22 (-1.06%)

NKE

Nike

$53.21

-0.025 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

CCL

Carnival

$65.80

2.3 (3.62%)

10:27
09/26/17
09/26
10:27
09/26/17
10:27
Hot Stocks
Carnival says booking volumes for 2018 ahead of prior year »

Says Booking volumes for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

10:25
09/26/17
09/26
10:25
09/26/17
10:25
General news
The 3.4% August U.S. new home sales drop »

The 3.4% August U.S. new…

X

U.S. Steel

$24.36

0.305 (1.27%)

10:21
09/26/17
09/26
10:21
09/26/17
10:21
Periodicals
U.S. Steel spokesperson tells Bloomberg company has not sold Slovak unit »

Bloomberg cites U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$24.36

0.305 (1.27%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Periodicals
Chinese company nearing acquisition of U.S. Steel's Kosice, Spectator reports »

The sale of U. S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$70.44

0.1 (0.14%)

, LLEX

Lilis Energy

$4.44

0.09 (2.07%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DWDP

DowDuPont

$70.44

0.1 (0.14%)

LLEX

Lilis Energy

$4.44

0.09 (2.07%)

ALDR

Alder Biopharmaceuticals

$11.15

0.3 (2.77%)

CORI

Corium

$10.88

0.03 (0.28%)

TGNA

Tegna

$12.92

0.06 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

JPM

JPMorgan

$93.84

-0.28 (-0.30%)

, PNC

PNC Financial

$132.62

-0.905 (-0.68%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

JPM

JPMorgan

$93.84

-0.28 (-0.30%)

PNC

PNC Financial

$132.62

-0.905 (-0.68%)

AFL

Aflac

$83.23

-1.03 (-1.22%)

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

CAKE

Cheesecake Factory

$41.60

0.08 (0.19%)

SHAK

Shake Shack

$31.60

-2.015 (-6.00%)

HABT

Habit Restaurants

GNCA

Genocea

$5.33

0.04 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Oct

  • 13

    Oct

  • 22

    Oct

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

DISCA

Discovery

$21.35

-0.06 (-0.28%)

, MO

Altria Group

$64.87

1.08 (1.69%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DISCA

Discovery

$21.35

-0.06 (-0.28%)

MO

Altria Group

$64.87

1.08 (1.69%)

LB

L Brands

$42.77

1.87 (4.57%)

SAM

Boston Beer

$159.25

6.25 (4.09%)

BTI

British American Tobacco

$62.01

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NKE

Nike

$53.28

0.05 (0.09%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Options
Nike option volume heavy pre-earnings with shares flat near $53.16 »

Nike option volume heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

10:20
09/26/17
09/26
10:20
09/26/17
10:20
General news
U.S. consumer confidence dipped 0.6 points to 119.8 in September »

U.S. consumer confidence…

CCL

Carnival

$65.92

2.4185 (3.81%)

, AAPL

Apple

$150.55

-1.34 (-0.88%)

10:18
09/26/17
09/26
10:18
09/26/17
10:18
Hot Stocks
Carnival to launch digital streaming channel Ocean View »

Continues to project cash…

CCL

Carnival

$65.92

2.4185 (3.81%)

AAPL

Apple

$150.55

-1.34 (-0.88%)

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.